1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2016

TitleJournalYearCitations
136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trialJournal of Thoracic Oncology2016169
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsOncotarget2016165
Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesLiver Cancer201680
LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) resultsJournal of Thoracic Oncology201679
A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapyBiomaterials201678
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal AdenocarcinomaClinical Chemistry201669
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastasesScience Translational Medicine201658
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 NanoparticlesACS Applied Materials & Interfaces201655
LBA1_PR: Osimertinib as first-line treatment for EGFR mutation-positive advanced NSCLC: updated efficacy and safety results from two Phase I expansion cohortsJournal of Thoracic Oncology201655
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerOncotarget201653
Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based StudyJournal of the National Cancer Institute201648
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian PopulationsJournal of Thoracic Oncology201646
Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical TrialsLiver Cancer201643
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)Annals of Oncology201639
Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cellsCancer Letters201637
A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.Journal of Clinical Oncology201637
MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling PathwaysInternational Journal of Molecular Sciences201635
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitorsJournal of Biomedical Science201635
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injectionAnnals of Hematology201633
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort studyBMC Cancer201632
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinomaCancer Letters201631
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 SuppressionClinical Cancer Research201628
Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cellsRna201626
RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated MalignancyAmerican Journal of Surgical Pathology201626
Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasionRadiotherapy and Oncology201625